Skip to main content

Diana Manos

Diana Manos is Senior Editor for Healthcare IT News. Located in Washington, D.C., she covers policy and legislation issues surrounding healthcare IT. Follow Diana on Twitter @DManos_IT_News.

By Diana Manos | 12:09 pm | May 04, 2009
By Diana Manos | 09:53 am | May 04, 2009
The Federal Trade Commission announced Friday that it will delay enforcement of the new "Red Flags Rule."
By Diana Manos | 05:06 pm | April 30, 2009
Amid a flurry of activity to pass comprehensive health reform by June, the White House says bipartisan support is preferable, but not necessary.
By Diana Manos | 04:52 pm | April 30, 2009
The Centers for Medicare and Medicaid Services have cut the national average fee-for-service growth rate for 2010 Medicare Advantage plans.
By Diana Manos | 10:34 am | April 30, 2009
The House and Senate approved a fiscal year 2010 budget on Wednesday that lays the groundwork for passage of a health reform package.
By Diana Manos | 11:04 am | April 29, 2009
Sen. Christopher Dodd (D-Conn.) told reporters Tuesday he is optimistic Democrats will work with Republicans on a health reform package.
By Diana Manos | 08:23 pm | April 27, 2009
A majority of healthcare leaders believe it's possible to hold healthcare spending steady over the next 10 years and say President Barack Obama's healthcare blueprint may be effective in doing so, according to a new survey.
By Diana Manos | 10:59 am | April 27, 2009
A small business owner from Seattle told White House officials Friday that providing health insurance for her employees is "a human thing" to do - even as rising healthcare costs and a sour economy are threatening to kill many small business owners' dreams.
By Diana Manos | 10:01 am | April 27, 2009
Six out of 10 U.S. hospitals have seen an increase in emergency room patients without insurance - while nearly half of all hospitals have cut staff.
By Diana Manos | 10:58 am | April 24, 2009
Sens. Charles Grassley (R-Iowa) and Edward Kennedy (D-Mass.) introduced legislation Thursday that would give the Food and Drug Administration more resources to inspect domestic and foreign-made prescription drugs and devices.